CLINICAL TRIAL EXPERIENCE WITH THE 9-VALENT HPV VACCINE BY RACE/ETHNICITY: A COMBINED ANALYSIS FROM SEVEN PHASE III CLINICAL STUDIES

被引：0
|
作者：
Clark, Liana R. [1 ]
Luxembourg, Alain T. [1 ]
机构：
[1] Merck & Co Inc, Rahway, NJ USA
来源：
JOURNAL OF ADOLESCENT HEALTH | 2016年 / 58卷 / 02期
关键词：
D O I：
10.1016/j.jadohealth.2015.10.246
中图分类号：
B844 [发展心理学（人类心理学）];
学科分类号：
040202 ;
摘要：
225
引用
收藏
页码：S118 / S118
页数：1
相关论文
共 50 条
  • [11] Head-to-head immunogenicity comparison of an Escherichia coli-produced 9-valent human papillomavirus vaccine and Gardasil 9 in women aged 18-26 years in China: a randomised blinded clinical trial
    Zhu, Feng-Cai
    Zhong, Guo-Hua
    Huang, Wei-Jin
    Chu, Kai
    Zhang, Li
    Bi, Zhao-Feng
    Zhu, Kong-Xin
    Chen, Qi
    Zheng, Ting-Quan
    Zhang, Ming-Lei
    Liu, Sheng
    Xu, Jin-Bo
    Pan, Hong-Xing
    Sun, Guang
    Zheng, Feng-Zhu
    Zhang, Qiu-Fen
    Yi, Xiu-Mei
    Zhuang, Si-Jie
    Huang, Shou-Jie
    Pan, Hui-Rong
    Su, Ying-Ying
    Wu, Ting
    Zhang, Jun
    Xia, Ning-Shao
    LANCET INFECTIOUS DISEASES, 2023, 23 (11): : 1313 - 1322
  • [12] Resistance profile of etravirine: combined analysis of baseline genotypic and phenotypic data from the randomized, controlled Phase III clinical studies
    Vingerhoets, Johan
    Tambuyzer, Lotke
    Azijn, Hilde
    Hoogstoel, Annemie
    Nijs, Steven
    Peeters, Monika
    de Bethune, Marie-Pierre
    De Smedt, Goedele
    Woodfall, Brian
    Picchio, Gaston
    AIDS, 2010, 24 (04) : 503 - 514
  • [13] Race and ethnicity in ulcerative colitis clinical trial enrolment: a post hoc analysis of patient demographics and clinical characteristics from GEMINI 1, VARSITY, and VISIBLE 1
    Khan, R. M. Q.
    Ananthakrishnan, A. N.
    Loftus, E. V., Jr.
    Iroku, U.
    Mukherjee, R.
    Uddin, S.
    Odufalu, F. D.
    Liu, J.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 977 - 979
  • [14] The Effect of Race on Treatment Response to Terlipressin in Patients with Hepatorenal Syndrome: A Pooled Analysis of 3 Phase III Clinical Studies
    Thuluvath, Paul J.
    Pyrsopoulos, Nikolaos T.
    Bhamidimarri, Kalyan Ram.
    Lim, Nicholas
    Jamil, Khurram
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S1083 - S1083
  • [15] A phase III clinical trial in Asia -: experience from the Asian Sildenafil (Viagra™) efficacy and safety study (ASSESS)
    Moreno, F
    Hayoun, H
    Ng, J
    ACTA PHARMACOLOGICA SINICA, 1998, 19 : 43 - 44
  • [16] A phase III clinical trial to evaluate the safety and immunogenicity of 23-valent pneumococcal polysaccharide vaccine (PPV23) in healthy children, adults, and elderly
    Huang, Lili
    Wang, Ling
    Li, Hong
    Hu, Yuansheng
    Ru, Weiping
    Han, Weixiao
    Shi, Gang
    Ye, Qiang
    Han, Zhen
    Xia, Jielai
    Xia, Shengli
    Xu, Miao
    Li, Jing
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2019, 15 (01) : 249 - 255
  • [17] Clinical trial experience with prophylactic HPV 6/11/16/18 VLP vaccine in young women from the Asia-Pacific region
    Tay, E. H.
    Garland, S.
    Tang, G.
    Nolan, T.
    Huang, L. -M.
    Orloski, L.
    Lu, S.
    Barr, E.
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2008, 102 (03) : 275 - 283
  • [18] Isavuconazole (ISA) Population Pharmacokinetic Modeling from Phase I and Phase III Clinical Trial and Target Attainment Analysis
    Desai, Amit
    Kovanda, Laura
    Kowalski, Donna
    Lu, Qaioyang
    Townsend, Robert
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2014, 41 : S66 - S66
  • [19] A post-hoc analysis of serotype-specific vaccine efficacy of 13-valent pneumococcal conjugate vaccine against clinical community acquired pneumonia from a randomized clinical trial in the Netherlands
    Gessner, Bradford D.
    Jiang, Qin
    Van Werkhoven, Cornelis H.
    Sings, Heather L.
    Webber, Chris
    Scott, Daniel
    Gruber, William C.
    Grobbee, Diederick E.
    Bonten, Marc J. M.
    Jodar, Luis
    VACCINE, 2019, 37 (30) : 4147 - 4154
  • [20] A phase III clinical trial in Asia-experience from the Asian Sildenafil (ViagraTM) efficacy and safety study (ASSESS)
    Acta Pharmacologica Sinica, 1998, (S1) : 46 - 47
12345